Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece - Concepedia

Concepedia

Publication | Closed Access

Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece

37

Citations

37

References

2019

Year

Theodoros V. Giannouchos, Dimos D. Mitsikostas, Robert L. Ohsfeldt, Athanassios Vozikis, Paraskevi Koufopoulou

Clinical Drug Investigation

Cluster HeadacheCost-effectiveness AnalysisChronic Migraine AttacksPain ManagementNeurologyMedicineErenumab Versus Onabotulinumtoxina

References

	Year	Citations

Page 1